{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T07:54:32Z","timestamp":1768290872247,"version":"3.49.0"},"reference-count":33,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JBM"],"DOI":"10.2147\/jbm.s236789","type":"journal-article","created":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T23:20:05Z","timestamp":1592781605000},"page":"213-225","source":"Crossref","is-referenced-by-count":8,"title":["<p>Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF\/FVIII Concentrate (Formulation V) in Pediatric Patients with von Willebrand Disease (SWIFTLY-VWD Study)<\/p>"],"prefix":"10.2147","volume":"Volume 11","author":[{"given":"Guenter","family":"Auerswald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Djambas Khayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8366-5926","authenticated-orcid":true,"given":"Oleksandra","family":"Stasyshyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genadi","family":"Iosava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4968-4461","authenticated-orcid":true,"given":"Irina","family":"Romashevskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta Julia","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilfried","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1674-1423","authenticated-orcid":true,"given":"Tobias","family":"Rogosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/ajh.10327","volume":"73","author":"Barr","year":"2003","journal-title":"Am J Hematol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"ref3","volume-title":"Textbook of Hemophilia","year":"2010"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s40265-017-0793-2","volume":"77","author":"Heijdra","year":"2017","journal-title":"Drugs"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1182\/blood.V97.7.1915","volume":"97","author":"Mannucci","year":"2001","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.2147\/TCRM.S87543","volume":"12","author":"Castaman","year":"2016","journal-title":"Ther Clin Risk Manag"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1046\/j.1365-2516.1999.0050s2028.x","volume":"5","author":"Federici","year":"1999","journal-title":"Haemophilia"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/bjh.13064","volume":"167","author":"Laffan","year":"2014","journal-title":"Br J Haematol"},{"key":"ref10","unstructured":"CSL Behring. VONCENTO\u00ae Summary of Product Characteristics. 2018. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/5341\/. Accessed June 22, 2018."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/MBC.0000000000000568","volume":"28","author":"Lissitchkov","year":"2017","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"212292","DOI":"10.7573\/dic.212292","volume":"5","author":"Harper","year":"2016","journal-title":"Drugs Context"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.thromres.2015.10.014","volume":"137","author":"Skotnicki","year":"2016","journal-title":"Thromb Res"},{"key":"ref14","unstructured":"EMA guideline on the clinical investigation of human plasma derived von Willebrand factor products (CPMP\/BPWG\/220\/02). Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2010\/01\/WC500067126.pdf. Accessed April 17, 2020."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3324\/haematol.11124","volume":"92","author":"Federici","year":"2007","journal-title":"Haematologica"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1160\/TH10-10-0631","volume":"105","author":"Windyga","year":"2011","journal-title":"Thromb Haemost"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/j.1538-7836.2007.02562.x","volume":"5","author":"Borel-Derlon","year":"2007","journal-title":"J Thromb Haemost"},{"key":"ref18","unstructured":"Shire. VONVENDI\u00ae Prescribing Information. 2018. Available from: https:\/\/www.shirecontent.com\/PI\/PDFs\/VONVENDI_USA_ENG.pdf. Accessed June 22, 2018."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1111\/j.1365-2516.2012.02758.x","volume":"18","author":"Coppola","year":"2012","journal-title":"Haemophilia"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","volume":"345","author":"Koster","year":"1995","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1055\/s-0037-1613227","volume":"88","author":"Makris","year":"2002","journal-title":"Thromb Haemost"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1055\/s-0037-1613225","volume":"88","author":"Mannucci","year":"2002","journal-title":"Thromb Haemost"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1182\/blood.V99.2.450","volume":"99","author":"Mannucci","year":"2002","journal-title":"Blood"},{"key":"ref24","unstructured":"CSL Behring. HAEMATE P\u00ae summary of product characteristics. 2018. Available from: https:\/\/www.medicines.org.uk\/emc\/medicine\/19412. Accessed June 22, 2018."},{"key":"ref25","unstructured":"LFB Biopharmaceuticals. WILLFACT\u00ae summary of product characteristics. 2016. Available from: https:\/\/www.medicines.org.uk\/emc\/medicine\/29947. Accessed June 22, 2018."},{"key":"ref26","unstructured":"Octapharma. WILATE\u00ae summary of product characteristics. 2014. Available from: https:\/\/www.medicines.org.uk\/emc\/medicine\/27202. Accessed June 22, 2018."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1160\/TH06-09-0495","volume":"97","author":"Favaloro","year":"2007","journal-title":"Thromb Haemost"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1365-2516.2010.02206.x","volume":"16","author":"Dunkley","year":"2010","journal-title":"Haemophilia"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1365-2516.2006.01430.x","volume":"13","author":"Shortt","year":"2007","journal-title":"Haemophilia"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1365-2516.2010.02445.x","volume":"17","author":"Howman","year":"2011","journal-title":"Haemophilia"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1600-0609.2008.01049.x","volume":"70","author":"Berntorp","year":"2008","journal-title":"Eur J Haematol Suppl"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1365-2516.2008.01901.x","volume":"15","author":"Berntorp","year":"2009","journal-title":"Haemophilia"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000338208","volume":"128","author":"Federici","year":"2012","journal-title":"Acta Haematol"}],"container-title":["Journal of Blood Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=59047","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=59047","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T23:20:11Z","timestamp":1592781611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/pharmacokinetics-efficacy-and-safety-of-a-plasma-derived-vwffviii-conc-peer-reviewed-article-JBM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":33,"URL":"https:\/\/doi.org\/10.2147\/jbm.s236789","relation":{},"ISSN":["1179-2736"],"issn-type":[{"value":"1179-2736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}